Soligenix, Inc. Press Releases

SNGX 
$1.62
*  
0.07
4.52 %
Get SNGX Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading SNGX now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Ricin Toxin Vaccine Poster Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC
2/13/2015 7:00:00 AM - PR Newswire


Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00
2/12/2015 9:00:00 AM - Market Wire


Preclinical Melioidosis Results Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC
2/11/2015 7:00:00 AM - PR Newswire


Soligenix to Present at the 17th Annual BIO CEO & Investor Conference in New York City
2/5/2015 7:00:00 AM - PR Newswire


TomaGold Corporation: IAMGOLD Intersects High Grade Gold at Monster Lake Project in Quebec
2/5/2015 7:00:00 AM - Market Wire


Soligenix Announces Presentation and Poster at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC
2/2/2015 7:00:00 AM - PR Newswire


FDA Grants Breakthrough Therapy Designation to LentiGlobin for Treatment of Beta-Thalassemia Major
2/2/2015 7:00:00 AM - Business Wire


Soligenix Announces Publication Successfully Demonstrating Enhanced Immunogenicity of its Heat-Stable Anthrax Vaccine
1/29/2015 7:00:00 AM - PR Newswire


FDA Grants Soligenix "Fast Track" Designation for SGX301 for the First-Line Treatment of Cutaneous T-Cell Lymphoma
1/7/2015 7:00:00 AM - PR Newswire


Celator® Pharmaceuticals Receives $1,937,000 from New Jersey's Technology Business Tax Certificate Transfer Program
1/5/2015 7:00:00 AM - PR Newswire


Soligenix Announces Positive Preliminary Nonclinical Results in Macrophage Activation Syndrome
1/5/2015 7:00:00 AM - PR Newswire


Soligenix Announces Publication of Combination Ricin/Anthrax Vaccine Data
12/29/2014 7:00:00 AM - PR Newswire


Soligenix Announces Closing of Public Offering of Units
12/24/2014 9:23:00 AM - PR Newswire


Soligenix Announces Pricing of Public Offering of Units
12/19/2014 8:24:00 AM - PR Newswire


Soligenix Receives $617,000 in Non-Dilutive Financing from New Jersey's Technology Business Tax Certificate Transfer Program
12/11/2014 7:00:00 AM - PR Newswire


Vista Partners Publishes December 2014 Macroeconomic & Investment Newsletter
12/2/2014 9:00:00 AM - Market Wire